SCHEMBL20008616

SCHEMBL20008616

Cc1ccc2cc3ccc(N(C)C)cc3nc2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 2/20 0.80
APP P05067 2/20 0.80
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
CYP1A2 P05177 3/20 0.50
APAF1 O14727 1/20 0.50
EGFR P00533 2/20 0.49
TSHR P16473 2/20 0.48
NQO2 P16083 1/20 0.45
KDM1A O60341 2/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine Orange SCHEMBL297155 0.89 TERT (1.00) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL29361720 0.89 TERT (1.00) TERTAPPALDH1A1KDM4EAPAF1
SCHEMBL9276222 0.88 APAF1 (0.64) TERTAPPALDH1A1KDM4EGAA
Acridine Orange SCHEMBL30153753 0.87 TERT (0.95) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL20816123 0.87 TERT (0.95) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL29597528 0.87 TERT (0.95) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL22071 0.87 TERT (0.95) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL8408019 0.85 APP (0.91) TERTAPPALDH1A1KDM4EAPAF1
Acridine Orange SCHEMBL31143792 0.85 TERT (0.91) TERTAPPALDH1A1APAF1EGFR
Acridine Orange SCHEMBL5859399 0.85 TERT (0.91) TERTAPPALDH1A1KDM4EAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180086713-A1 CGAS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) UNIVERSITY OF WASHINGTON 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086713-A1 CGAS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) STING1, IRF3, CGAS TERT 3483/4885APP 3191/4885ALDH1A1 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.